Cumberland Pharmaceuticals INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cumberland Pharmaceuticals Inc. will hold its annual shareholder meeting on April 22, 2025, to vote on the election of directors and the ratification of its independent accounting firm.
NASDAQ
Cumberland Pharmaceuticals will hold its Annual Meeting of Shareholders on April 22, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Cumberland Pharmaceuticals Inc. will hold its annual shareholder meeting on April 23, 2024, to vote on director elections and ratify the appointment of its independent accounting firm.
NASDAQ
DEF 14A: Cumberland Pharmaceuticals Sets Date for 2024 Annual Shareholder Meeting, Outlines Key Proposals
Cumberland Pharmaceuticals will hold its annual shareholder meeting on April 23, 2024, to vote on director elections and the ratification of its independent accounting firm.